Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck Jumps On Neurostim Technology, Signing Agreements With Start-Ups

Executive Summary

The biotech giant signed a commercial agreement with bioelectronics company Innervia, and the two will work collaboratively on vagus nerve stimulating technologies. 

You may also be interested in...



Startup Spotlight: INBRAIN Hopes To Leapfrog Brain Electrode Competition

By utilizing the properties of graphene, INBRAIN hopes to develop improved electrodes implanted in the brain, raising the potential of neuromodulation for treating complex neurological disorders.

Market Intel: Expanding Applications And Improved Offerings To Drive Robotically Assisted Surgery Market

The global market for robotically assisted surgical devices will reach $11.5bn by 2025 as system improvements drive sales.

Start-Up Spotlight: Grapheal Unlocking Graphene’s Potential In Wound Healing

The company has developed a biosensor that provides information to health care professionals concerning the health of a patient’s wound.

Topics

Related Companies

UsernamePublicRestriction

Register

MT144238

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel